We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

17 hedge funds and large institutions have $17.4M invested in VolitionRx Ltd in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

0.04% more ownership

Funds ownership: 0.89% → 0.93% (+0.04%)

0% more funds holding

Funds holding: 17 → 17 (0)

8% less capital invested

Capital invested by funds: $18.8M → $17.4M (-$1.44M)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
–
Increased
5
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$781K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$70K
3
UBS Group
UBS Group
Switzerland
+$6.28K
4
TRCT
Tower Research Capital (TRC)
New York
+$2.6K
5
BlackRock
BlackRock
New York
+$1.8K

Top Sellers

Rank Fund Capital Flow
1
SCA
Southpoint Capital Advisors
New York
-$28.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$11.2M +$781K +10,831 +7%
SCA
2
Southpoint Capital Advisors
New York
$2.8M -$28.9K -400 -1%
KCM
3
Knoll Capital Management
Florida
$1.62M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$725K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$357K – – –
Morgan Stanley
6
Morgan Stanley
New York
$209K – – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$108K +$70K +971 +177%
Northern Trust
8
Northern Trust
Illinois
$80K – – –
GBA
9
Garrison Bradford & Associates
New York
$55K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$50K – – –
Creative Planning
11
Creative Planning
Kansas
$47K – – –
BlackRock
12
BlackRock
New York
$38K +$1.8K +25 +5%
Bessemer Group
13
Bessemer Group
New Jersey
$35K – – –
AG
14
Advisor Group
Arizona
$27K – – –
UBS Group
15
UBS Group
Switzerland
$19K +$6.28K +87 +49%
TRCT
16
Tower Research Capital (TRC)
New York
$4K +$2.6K +36 +144%
IP
17
Intellectus Partners
California
$1K – – –

VNRX Hedge Fund Activity: Q2 2017 in Review

17 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2017, worth a combined $17.4M — down 7.6% from $18.8M a quarter earlier.

Fund positioning in VNRX was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Lagoda Investment Management, adding an estimated $781K. The largest seller was Southpoint Capital Advisors, cutting an estimated $28.9K.

  • 17 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $17.4M of VolitionRx Ltd stock for Q2 2017, down 7.6% quarter-over-quarter.
  • 0 funds opened new VolitionRx Ltd positions in Q2 2017 and 0 closed out.
  • The largest VolitionRx Ltd buyer in Q2 2017 was Lagoda Investment Management, an estimated $781K added.
  • The largest VolitionRx Ltd seller in Q2 2017 was Southpoint Capital Advisors, an estimated $28.9K sold.

Based on aggregated 13F filings for Q2 2017.